Literature DB >> 8612664

Differential kinetics of [123I]beta-CIT binding to dopamine and serotonin transporters.

M Fujita1, K Takatoku, Y Matoba, M Nishiura, K Kobayashi, O Inoue, T Nishimura.   

Abstract

Iodine-123-labelled 3beta-(4-iodophenyl)tropane-2beta-carboxylic acid ([123I]beta-CIT) labels both the dopamine transporter (DAT) and the serotonin transporter (5-HTT) and this ligand is able to clarify pathological changes in both dopaminergic and serotonergic systems. However, the differential kinetics of beta-CIT binding to DAT and 5-HTT has not been clarified fully. In this study we examined time-activity curves of [123I]beta-CIT in individual regions in the rat brain. Using cerebellum as the reference region, k3 and k4 values were estimated by a two-compartment kinetic analysis. In the striatum, the kinetics was slowest among all brain areas. In this area specific binding reached its peak 4 h after the injection. In the hypothalamus, specific binding reached its peak 1 h after the injection and its amount did not change until 4 h after the injection. In the occipital cortex, the binding and washout of the ligand were fastest among all brain regions. Estimated k3 values were 0.040+/-0.003 in the striatum, 0.019+/-0.002 in the hypothalamus and 0.082+/-0.011 in the occipital cortex (min-1, mean +/-SD). Estimated k4 values were 0.0034+/-0.0005 in the striatum, 0.0071+/-0.0009 in the hypothalamus and 0.083+/-0.013 in the occipital cortex (min-1, mean +/-SD). Therefore binding kinetics of [123i]beta-cit in the region rich in dat is apparently different from that in the region rich in 5-HTT. These results will provide fundamental data to image both DAT and 5-HTT in one series of examinations with [123I]beta-CIT.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8612664     DOI: 10.1007/bf01247372

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  35 in total

1.  Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression, and suicides.

Authors:  T J Crow; A J Cross; S J Cooper; J F Deakin; I N Ferrier; J A Johnson; M H Joseph; F Owen; M Poulter; R Lofthouse
Journal:  Neuropharmacology       Date:  1984-12       Impact factor: 5.250

2.  An increase in the in vivo binding of [3H]SCH 23390 induced by MK-801 in the mouse striatum.

Authors:  K Kobayashi; O Inoue
Journal:  Neuropharmacology       Date:  1993-04       Impact factor: 5.250

3.  SPECT imaging of dopamine and serotonin transporters with [123I]beta-CIT: pharmacological characterization of brain uptake in nonhuman primates.

Authors:  M Laruelle; R M Baldwin; R T Malison; Y Zea-Ponce; S S Zoghbi; M S al-Tikriti; E H Sybirska; R C Zimmermann; G Wisniewski; J L Neumeyer
Journal:  Synapse       Date:  1993-04       Impact factor: 2.562

4.  [123/125I]RTI-55, an in vivo label for the serotonin transporter.

Authors:  U Scheffel; R F Dannals; E J Cline; G A Ricaurte; F I Carroll; P Abraham; A H Lewin; M J Kuhar
Journal:  Synapse       Date:  1992-06       Impact factor: 2.562

5.  Initial experience with single-photon emission tomography using iodine-123-labelled 2 beta-carbomethoxy-3 beta-(4-iodophenyl) tropane in human brain.

Authors:  J T Kuikka; K A Bergström; E Vanninen; V Laulumaa; P Hartikainen; E Länsimies
Journal:  Eur J Nucl Med       Date:  1993-09

6.  Regional brain uptake and pharmacokinetics of [123I]N-omega-fluoroalkyl-2 beta-carboxy-3 beta-(4-iodophenyl)nortropane esters in baboons.

Authors:  R M Baldwin; Y Zea-Ponce; M S al-Tikriti; S S Zoghbi; J P Seibyl; D S Charney; P B Hoffer; S Wang; R A Milius; J L Neumeyer
Journal:  Nucl Med Biol       Date:  1995-02       Impact factor: 2.408

7.  Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease.

Authors:  R B Innis; J P Seibyl; B E Scanley; M Laruelle; A Abi-Dargham; E Wallace; R M Baldwin; Y Zea-Ponce; S Zoghbi; S Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

8.  Imaging of serotonin and dopamine transporters in the living human brain.

Authors:  J T Kuikka; J Tiihonen; K A Bergström; J Karhu; P Hartikainen; H Viinamäki; E Länsimies; J Lehtonen; P Hakola
Journal:  Eur J Nucl Med       Date:  1995-04

9.  High-affinity binding of [125I]RTI-55 to dopamine and serotonin transporters in rat brain.

Authors:  J W Boja; W M Mitchell; A Patel; T A Kopajtic; F I Carroll; A H Lewin; P Abraham; M J Kuhar
Journal:  Synapse       Date:  1992-09       Impact factor: 2.562

10.  Distinct kinetic binding properties of N-[3H]-methylscopolamine afford differential labeling and localization of M1, M2, and M3 muscarinic receptor subtypes in primate brain.

Authors:  D D Flynn; D C Mash
Journal:  Synapse       Date:  1993-08       Impact factor: 2.562

View more
  2 in total

1.  A new model for separation between brain dopamine and serotonin transporters in 123I-beta-CIT SPECT measurements: normal values and sex and age dependence.

Authors:  Erik Ryding; Mats Lindström; Björn Brådvik; Martin Grabowski; Peter Bosson; Lil Träskman-Bendz; Ingmar Rosén
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-03-11       Impact factor: 9.236

2.  Advanced brain dopamine transporter imaging in mice using small-animal SPECT/CT.

Authors:  Miia Pitkonen; Eero Hippeläinen; Mari Raki; Jaan-Olle Andressoo; Arto Urtti; Pekka T Männistö; Sauli Savolainen; Mart Saarma; Kim Bergström
Journal:  EJNMMI Res       Date:  2012-09-29       Impact factor: 3.138

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.